Travoprost
Travoprost (Travoprostum) is a PGF2a analog that was launched as an ophthalmic solution administered topically for the treatment of elevated intraocular hypertension as a result of open-angle glaucoma, a common optic neuropathy, and a leading cause of blindness. It can act as an agonist of prostaglandin F receptor.
| Trivial name | Travoprostum |
| Catalog Number | S3738 |
| Molecular Formula | C19H20F3N5O5S2 |
| CAS# | 157283-68-6 |
| Inchi | InChI=1S/C19H20F3N5O5S2/c20-19(21,22)33-12-3-1-2-10(6-12)13-8-16-24-5-4-15(27(16)26-13)25-14-7-11(17(28)18(14)29)9-32-34(23,30)31/h1-6,8,11,14,17-18,25,28-29H,7,9H2,(H2,23,30,31)/t11-,14-,17-,18+/m1/s 1 |
| Inchi Key | KJDAGXLMHXUAGV-DGWLBADLSA-N |
| SMILES | N[S;v6](=O)(=O)OCC1CC(NC2=CC=NC3=CC(=N[N]23)C4=CC(=CC=C4)SC(F)(F)F)C(O)C1O |
| Size | 2mg |
| Supplier Page | http://www.selleckchem.com/products/travoprost.html |
| Additional Information | https://file.selleck.cn/downloads/struct/travoprost-chemical-structure-s3738.gif |